863 related articles for article (PubMed ID: 19567408)
1. Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism.
Beeton ML; Chalker VJ; Kotecha S; Spiller OB
J Antimicrob Chemother; 2009 Sep; 64(3):529-38. PubMed ID: 19567408
[TBL] [Abstract][Full Text] [Related]
2. Analysis of mutations in DNA gyrase and topoisomerase IV of Ureaplasma urealyticum and Ureaplasma parvum serovars resistant to fluoroquinolones.
Piccinelli G; Gargiulo F; Biscaro V; Caccuri F; Caruso A; De Francesco MA
Infect Genet Evol; 2017 Jan; 47():64-67. PubMed ID: 27884651
[TBL] [Abstract][Full Text] [Related]
3. Study of isolation of fluoroquinolone-resistant Ureaplasma urealyticum and identification of mutant sites.
Zhang W; Wu Y; Yin W; Yu M
Chin Med J (Engl); 2002 Oct; 115(10):1573-5. PubMed ID: 12490114
[TBL] [Abstract][Full Text] [Related]
4. Detection of mutations in Salmonella enterica gyrA, gyrB, parC and parE genes by denaturing high performance liquid chromatography (DHPLC) using standard HPLC instrumentation.
Randall LP; Coldham NG; Woodward MJ
J Antimicrob Chemother; 2005 Oct; 56(4):619-23. PubMed ID: 16141278
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV.
Touyama M; Higa F; Nakasone C; Shinzato T; Akamine M; Haranaga S; Tateyama M; Nakasone I; Yamane N; Fujita J
J Antimicrob Chemother; 2006 Dec; 58(6):1279-82. PubMed ID: 17056610
[TBL] [Abstract][Full Text] [Related]
6. Frequent topoisomerase IV mutations associated with fluoroquinolone resistance in Ureaplasma species.
Song J; Qiao Y; Kong Y; Ruan Z; Huang J; Song T; Zhang J; Xie X
J Med Microbiol; 2015 Nov; 64(11):1315-1320. PubMed ID: 26243148
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of five quinolones and analysis of the quinolone resistance-determining regions of gyrA, gyrB, parC, and parE in Ureaplasma parvum and Ureaplasma urealyticum clinical isolates from perinatal patients in Japan.
Kawai Y; Nakura Y; Wakimoto T; Nomiyama M; Tokuda T; Takayanagi T; Shiraishi J; Wasada K; Kitajima H; Fujita T; Nakayama M; Mitsuda N; Nakanishi I; Takeuchi M; Yanagihara I
Antimicrob Agents Chemother; 2015 Apr; 59(4):2358-64. PubMed ID: 25645833
[TBL] [Abstract][Full Text] [Related]
8. Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance.
Shimada Y; Deguchi T; Nakane K; Masue T; Yasuda M; Yokoi S; Ito S; Nakano M; Ito S; Ishiko H
Int J Antimicrob Agents; 2010 Sep; 36(3):255-8. PubMed ID: 20580532
[TBL] [Abstract][Full Text] [Related]
9. Trends in the rates of resistance of Ureaplasma urealyticum to antibiotics and identification of the mutation site in the quinolone resistance-determining region in Chinese patients.
Xie X; Zhang J
FEMS Microbiol Lett; 2006 Jun; 259(2):181-6. PubMed ID: 16734777
[TBL] [Abstract][Full Text] [Related]
10. Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates.
Moon DC; Seol SY; Gurung M; Jin JS; Choi CH; Kim J; Lee YC; Cho DT; Lee JC
Int J Antimicrob Agents; 2010 Jan; 35(1):76-9. PubMed ID: 19781915
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the gyrB, parC, and parE genes of quinolone-resistant isolates and mutants of Edwardsiella tarda.
Kim MS; Jun LJ; Shin SB; Park MA; Jung SH; Kim K; Moon KH; Jeong HD
J Microbiol Biotechnol; 2010 Dec; 20(12):1735-43. PubMed ID: 21193831
[TBL] [Abstract][Full Text] [Related]
12. Mutational paths towards increased fluoroquinolone resistance in Legionella pneumophila.
Almahmoud I; Kay E; Schneider D; Maurin M
J Antimicrob Chemother; 2009 Aug; 64(2):284-93. PubMed ID: 19474069
[TBL] [Abstract][Full Text] [Related]
13. Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa.
Lee JK; Lee YS; Park YK; Kim BS
Int J Antimicrob Agents; 2005 Apr; 25(4):290-5. PubMed ID: 15784307
[TBL] [Abstract][Full Text] [Related]
14. Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China.
Pu XY; Pan JC; Wang HQ; Zhang W; Huang ZC; Gu YM
J Antimicrob Chemother; 2009 May; 63(5):917-20. PubMed ID: 19297378
[TBL] [Abstract][Full Text] [Related]
15. [Fluoroquinolone resistance mutations in topoisomerase genes of Salmonella typhimurium isolates].
Guo Y; Pei X; Liu X
Wei Sheng Yan Jiu; 2004 Sep; 33(5):591-4. PubMed ID: 15612489
[TBL] [Abstract][Full Text] [Related]
16. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
Turner AK; Nair S; Wain J
J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of mutations in DNA gyrase and topoisomerase IV genes contributes to fluoroquinolone resistance in Vibrio cholerae O139 strains.
Zhou Y; Yu L; Li J; Zhang L; Tong Y; Kan B
Int J Antimicrob Agents; 2013 Jul; 42(1):72-5. PubMed ID: 23643392
[TBL] [Abstract][Full Text] [Related]
18. Emerging fluoroquinolone-non-susceptible group A streptococci in two different paediatric populations.
Smeesters PR; Vergison A; Junior DC; Van Melderen L
Int J Antimicrob Agents; 2009 Jul; 34(1):44-9. PubMed ID: 19269141
[TBL] [Abstract][Full Text] [Related]
19. Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae: data from the global PROTEKT surveillance programme.
Canton R; Morosini M; Enright MC; Morrissey I
J Antimicrob Chemother; 2003 Dec; 52(6):944-52. PubMed ID: 14585861
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the quinolone-resistance determining region of the gyrA gene and the analogous region of the parC gene in Ureaplasma parvum and Ureaplasma urealyticum detected in first-void urine of men with non-gonococcal urethritis.
Kamiya Y; Shimada Y; Ito S; Kikuchi M; Yasuda M; Kawamura Y; Deguchi T
J Antimicrob Chemother; 2013 Feb; 68(2):480-2. PubMed ID: 23090978
[No Abstract] [Full Text] [Related]
[Next] [New Search]
